BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
HIV infection
,
Kidney
,
Holistic medicine
,
Fenofibrate
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cathepsins d
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Steroid effect on HUVEC response to LPS or cytokines
Explore Curated Studies Results
Literature
Most Relevant Literature
Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective.
The entomotoxin Jack Bean Urease changes cathepsin D activity in nymphs of the hematophagous insect …
Oxidation of Cathepsin D by Hydroxy Radical: Its Effect on Enzyme Structure and Activity against Myo…
Role of cathepsin D induced by Porphyromonas gingivalis lipopolysaccharide in periodontitis.
The behavior of cathepsin D during milk processing and its contribution to bitterness in a model fre…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lymphangioleiomyomatosis, a Study on Cathepsin K
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ